The FDA has taken a significant step in sodium reduction by adopting a phased and data-driven approach, publishing a draft guidance for the second phase of voluntary sodium reduction targets. This initiative aims to support sodium reduction across the food supply chain. Prior to 2021, the average daily sodium intake of consumers was approximately 3,400 milligrams. If the draft guidance is finalized, the new voluntary targets will help reduce individual sodium intake to an average of 2,750 milligrams. This reduction represents about a 20% decrease from pre-2021 levels. The second-phase sodium reduction targets are a continuation of the first targets published in October 2021.